The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the ...

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for ...

Michael Botta is co-founder and president of Sesame, a health-care marketplace.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.